These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 28404521)

  • 21. [The research progress of relationship between advanced glycation end products and diabetic keratopathy].
    Dan J; Zhou QJ; Xie LX
    Zhonghua Yan Ke Za Zhi; 2018 Jun; 54(6):475-480. PubMed ID: 29895121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNase I improves corneal epithelial and nerve regeneration in diabetic mice.
    Zhang J; Dai Y; Wei C; Zhao X; Zhou Q; Xie L
    J Cell Mol Med; 2020 Apr; 24(8):4547-4556. PubMed ID: 32168430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed wound closure and phenotypic changes in corneal epithelium of the spontaneously diabetic Goto-Kakizaki rat.
    Wakuta M; Morishige N; Chikama T; Seki K; Nagano T; Nishida T
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):590-6. PubMed ID: 17251454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dr. P. Siva Reddy Oration. Diabetic keratopathy.
    Rao GN
    Indian J Ophthalmol; 1987; 35(5-6):16-36. PubMed ID: 3508767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epalrestat improves diabetic wound healing via increased expression of nerve growth factor.
    Nakagaki O; Miyoshi H; Sawada T; Atsumi T; Kondo T; Atsumi T
    Exp Clin Endocrinol Diabetes; 2013 Feb; 121(2):84-9. PubMed ID: 23426701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of the polyol pathway in the occurrence of degenerative complications of diabetes].
    Bosquet F; Grimaldi A
    Presse Med; 1986 May; 15(19):879-83. PubMed ID: 3012508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effect of Tephrosia purpurea in diabetic cataract through aldose reductase inhibitory activity.
    Bhadada SV; Vyas VK; Goyal RK
    Biomed Pharmacother; 2016 Oct; 83():221-228. PubMed ID: 27372406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetic keratopathy.
    Yeung A; Dwarakanathan S
    Dis Mon; 2021 May; 67(5):101135. PubMed ID: 33551178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuronal Changes in the Diabetic Cornea: Perspectives for Neuroprotection.
    Bikbova G; Oshitari T; Baba T; Yamamoto S
    Biomed Res Int; 2016; 2016():5140823. PubMed ID: 28044131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic-like corneal sensitivity loss in galactose-fed rats ameliorated with aldose reductase inhibitors.
    Jacot JL; Hosotani H; Glover JP; Lois N; Robison WG
    J Ocul Pharmacol Ther; 1998 Apr; 14(2):169-80. PubMed ID: 9572543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-204-5p-Mediated Regulation of SIRT1 Contributes to the Delay of Epithelial Cell Cycle Traversal in Diabetic Corneas.
    Gao J; Wang Y; Zhao X; Chen P; Xie L
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(3):1493-504. PubMed ID: 25613939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does aldose reductase have a role in the development of the ocular complications of diabetes?
    Lightman S
    Eye (Lond); 1993; 7 ( Pt 2)():238-41. PubMed ID: 7607342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diabetic complications within ocular surface].
    Wylegała E; Moćko L; Woyna-Orlewicz A; Teper S; Orzechowska-Wylegała B
    Pol Merkur Lekarski; 2006 Nov; 21(125):495-7. PubMed ID: 17345849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Functional morphology of the cornea].
    Leuenberger PM
    Adv Ophthalmol; 1978; 35():94-166. PubMed ID: 626123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neurotrophic keratopathy--studies on substance P and the clinical significance of corneal sensation].
    Nishida T; Nakamura M; Konma T; Ofuji K; Nagano K; Tanaka T; Enoki M; Reid TW; Brown SM; Murphy CJ; Mannis MJ
    Nippon Ganka Gakkai Zasshi; 1997 Dec; 101(12):948-74. PubMed ID: 9436358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thymosin Beta 4: A Potential Novel Therapy for Neurotrophic Keratopathy, Dry Eye, and Ocular Surface Diseases.
    Sosne G; Rimmer D; Kleinman HK; Ousler G
    Vitam Horm; 2016; 102():277-306. PubMed ID: 27450739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy.
    Yamada N; Matsuda R; Morishige N; Yanai R; Chikama TI; Nishida T; Ishimitsu T; Kamiya A
    Br J Ophthalmol; 2008 Jul; 92(7):896-900. PubMed ID: 18511539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical aldose reductase inhibitor for correcting corneal endothelial changes in diabetic patients.
    Ohguro N; Matsuda M; Ohashi Y; Fukuda M
    Br J Ophthalmol; 1995 Dec; 79(12):1074-7. PubMed ID: 8562538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corneal alteration and pathogenesis in diabetes mellitus.
    Zhao H; He Y; Ren YR; Chen BH
    Int J Ophthalmol; 2019; 12(12):1939-1950. PubMed ID: 31850180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptide therapies for ocular surface disturbances based on fibronectin-integrin interactions.
    Nishida T; Inui M; Nomizu M
    Prog Retin Eye Res; 2015 Jul; 47():38-63. PubMed ID: 25645519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.